Reuters logo
BRIEF-Sensorion selects new drug for disorders with inner ear lesions
September 29, 2016 / 5:26 PM / in a year

BRIEF-Sensorion selects new drug for disorders with inner ear lesions

Sept 29 (Reuters) - Sensorion SA :

* Sensorion selects new drug candidate, SENS-401, to treat vestibular and auditory disorders associated with inner ear lesions

* SENS-401 will also strengthen sensorion’s intellectual property portfolio, and company has filed new patent applications to seek commercial exclusivity for SENS-401 until 2036

* Sensorion has decided to select SENS-401, instead of 218, as its final drug candidate for treating lesions of inner ear Source text for Eikon: Further company coverage: (Gdynia Newsroom)

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below